Price Data Unavailable
Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Next stock AMPS
Previous stock ALVO
WallstreetBets Trending Stocks (24h)